The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.
Exclusive: It wasn't until Ke Huy Quan realized that Love Hurts was going to introduce a different kind of hero that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback